Clinical Trials
31 trialsAutologous BCMA-targeted CAR-T Cell Injection for Relapsed/Refractory Light Chain Amyloidosis
Beijing Boren Hospital
A Study Investigating Coagadex in the Treatment AFXD Associated With AL Amyloidosis
Kedrion S.p.A.
Phase 1/2a Study of Belantamab Mafodotin in Relapsed or Refractory AL Amyloidosis
University of Texas Southwestern Medical Center
Comparing Dara-VCD Chemotherapy Plus Stem Cell Transplant to Dara-VCD Chemotherapy Alone for People Who Have Newly Diagnosed AL Amyloidosis
SWOG Cancer Research Network
ALPS
Fondazione IRCCS Policlinico San Matteo di Pavia
Study of GC012F, CAR-T Therapy Targeting CD19 and BCMA in Chinese Participants With Relapsed or Refractory AL Amyloidosis
Gracell Biotechnologies (Shanghai) Co., Ltd.
A Phase II Trial of Teclistamab in Participants With Previously Treated Immunoglobulin Light-chain (AL) Amyloidosis
European Myeloma Network B.V.
ReAL
Fondazione IRCCS Policlinico San Matteo di Pavia
EUREKA
Fondazione IRCCS Policlinico San Matteo di Pavia
ProDigALIty
Fondazione IRCCS Policlinico San Matteo di Pavia
Daratumumab Maintenance Therapy for Improving Survival in Patients With Light Chain Amyloidosis, EMILIA Trial
Mayo Clinic
ITA-WebNet
Fondazione IRCCS Policlinico San Matteo di Pavia
ALACRITY
Alexion Pharmaceuticals, Inc.
B-SCR-MM
Ohio State University Comprehensive Cancer Center
Optimize First-line Treatment for AL Amyloidosis With t (11; 14)
Peking University People's Hospital
Rapid dFLC Response Predict CHR in AL Amyloidosis
Peking University People's Hospital
Elranatamab in Patients With Relapsed or Refractory AL Amyloidosis
Brigham and Women's Hospital
GlycAL
Fondazione IRCCS Policlinico San Matteo di Pavia
BE.Amycon Biobank & Data Registry UZ Leuven
Universitaire Ziekenhuizen KU Leuven
Collection of Samples and Clinical Data From Patients With Amyloid Diseases
Boston Medical Center
Teclistamab-Daratumumab in AL Amyloidosis
Columbia University
MICA
Brigham and Women's Hospital
Tissue, Blood, and Body Fluid Sample Collection From Patients With Hematologic Cancer
UNC Lineberger Comprehensive Cancer Center
EAR
University Hospital, Essen
Screening for AL Amyloidosis in Smoldering Multiple Myeloma
Tufts Medical Center
Safety and Efficacy of Metabolically Armed BCMA CAR-T Cells (Meta10-BCMA) in the Treatment of r/r Plasma Cell Neoplasms Clinical Research
Anhui Provincial Hospital
Teclistamab in Newly Diagnosed Mayo Stage IIIB AL Amyloidosis
Peking Union Medical College Hospital
NEXICART-2
Nexcella Inc.
3'-Deoxy-3'-[18F] Fluorothymidine PET Imaging in Patients With Cancer
Barbara Ann Karmanos Cancer Institute
Venetoclax-Dexamethasone in Relapsed and/or Refractory t(11;14) Amyloidosis
Columbia University
Registry of Older Patients With Cancer
UNC Lineberger Comprehensive Cancer Center